• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚山梨醇酯80的异常浑浊行为——解析未酯化成分的作用

Anomalous Clouding Behavior of Polysorbate 80─Deciphering the Role of Nonesterified Components.

作者信息

Hassan Alaa, Diederichs Tim, Garidel Patrick, Heerklotz Heiko

机构信息

Institute of Pharmaceutical Sciences, Department of Pharmaceutics, University of Freiburg, Hermann-Herder-Str. 9, Freiburg 79104, Germany.

Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt.

出版信息

Mol Pharm. 2025 Jun 2;22(6):2917-2926. doi: 10.1021/acs.molpharmaceut.4c01268. Epub 2025 May 14.

DOI:10.1021/acs.molpharmaceut.4c01268
PMID:40365937
Abstract

Polysorbates (PSs) are key excipients for the colloidal stability of biopharmaceuticals with unique properties. A comprehensive understanding of the physicochemical properties of these multicomponent products is essential to address potential stability issues without compromising their functionality. Here, we demonstrate that polysorbate 80 HP (PS80) shows an anomalous clouding, i.e., a thermotropic liquid-liquid phase separation behavior, which cannot adequately be explained by the conventional interpretation assuming a pseudobinary system. In a binary two-phase system of surfactant and buffer, an increase in the total surfactant concentration increases the fraction of the surfactant-rich phase in the respective proportion (lever rule). PS80 within about 7 K of the lower critical solution temperature fails to comply with this; concentrations and compositions of the coexisting phases change with the total concentration. This renders the phases more alike and, at some point, eliminates phase separation. This significant deviation from the pseudobinary phase behavior can be resolved by conceptually dividing the numerous chemical species in PS80 into two independent pseudocomponents, PS80-I and -II. Ternary phase diagrams derived from this approach successfully explain the observed anomalous behavior. RP-UPLC-MS analysis indicated a concentration-dependent redistribution of the nonesterified components (NECs), suggesting, along with other evidence, that NECs are key constituents of component II. Specifically, free polyethylene glycol (PEG) and/or PEG-sorbitans seem to function as intrinsic cosurfactant(s) within PS80, modulating its wetting and clouding properties. The latter is important for interaction, association, and phase separation properties in biologics.

摘要

聚山梨酯(PSs)是具有独特性质的生物药物胶体稳定性的关键辅料。全面了解这些多组分产品的物理化学性质对于解决潜在的稳定性问题而不损害其功能至关重要。在此,我们证明聚山梨酯80 HP(PS80)表现出异常的浑浊现象,即热致液-液相分离行为,这无法用假设为假二元体系的传统解释充分解释。在表面活性剂和缓冲液的二元两相体系中,总表面活性剂浓度的增加会按相应比例增加富含表面活性剂相的比例(杠杆规则)。在较低临界溶液温度约7 K范围内的PS80并不符合此规律;共存相的浓度和组成随总浓度而变化。这使得各相更加相似,并且在某一时刻消除了相分离。通过将PS80中的众多化学物质概念性地分为两个独立的假组分PS80-I和-II,可以解决与假二元相行为的这一显著偏差。由此方法得出的三元相图成功地解释了观察到的异常行为。RP-UPLC-MS分析表明未酯化成分(NECs)存在浓度依赖性的重新分布,这与其他证据一起表明NECs是组分II的关键成分。具体而言,游离聚乙二醇(PEG)和/或聚乙二醇脱水山梨醇似乎在PS80中作为内在的共表面活性剂发挥作用,调节其润湿性和浑浊特性。后者对于生物制品中的相互作用、缔合和相分离特性很重要。

相似文献

1
Anomalous Clouding Behavior of Polysorbate 80─Deciphering the Role of Nonesterified Components.聚山梨醇酯80的异常浑浊行为——解析未酯化成分的作用
Mol Pharm. 2025 Jun 2;22(6):2917-2926. doi: 10.1021/acs.molpharmaceut.4c01268. Epub 2025 May 14.
2
Study of phase behavior of poly(ethylene glycol)-polysorbate 80 and poly(ethylene glycol)-polysorbate 80-water mixtures.聚乙二醇-聚山梨酯80以及聚乙二醇-聚山梨酯80-水混合物的相行为研究
J Pharm Sci. 2000 Jul;89(7):946-50. doi: 10.1002/1520-6017(200007)89:7<946::AID-JPS12>3.0.CO;2-2.
3
Complex Micellization Behavior of the Polysorbates Tween 20 and Tween 80.聚山梨酯 20 和聚山梨酯 80 的复杂胶束化行为。
Mol Pharm. 2021 Aug 2;18(8):3147-3157. doi: 10.1021/acs.molpharmaceut.1c00406. Epub 2021 Jul 12.
4
Comparative analysis and mechanistic insights into polysorbate 80 stability differences in biopharmaceutical buffer systems.生物制药缓冲体系中聚山梨酯80稳定性差异的比较分析及作用机制洞察
Eur J Pharm Biopharm. 2024 Dec;205:114521. doi: 10.1016/j.ejpb.2024.114521. Epub 2024 Oct 9.
5
Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody.聚山梨酯 80 的水解和氧化对单克隆抗体聚集的影响比较。
J Pharm Sci. 2020 Jan;109(1):633-639. doi: 10.1016/j.xphs.2019.10.069. Epub 2019 Nov 20.
6
Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.研究表面活性剂/助表面活性剂协同作用对布洛芬增溶能力和非离子型微乳释药特性的影响。
Int J Pharm. 2012 Aug 20;433(1-2):25-33. doi: 10.1016/j.ijpharm.2012.04.070. Epub 2012 May 3.
7
Impact of citrate on mitigating iron mediated polysorbate 80 degradation in biotherapeutic formulation placebos.柠檬酸盐对减轻生物治疗制剂安慰剂中由铁介导的聚山梨醇酯80降解的影响。
J Pharm Sci. 2025 Feb;114(2):857-865. doi: 10.1016/j.xphs.2024.10.038. Epub 2024 Nov 14.
8
On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations.在线疏水相互作用柱与反相柱-带电气溶胶检测器/质谱联用对治疗性蛋白制剂中的聚山梨酯进行表征。
J Chromatogr A. 2019 Feb 8;1586:72-81. doi: 10.1016/j.chroma.2018.11.080. Epub 2018 Dec 5.
9
What Makes Polysorbate Functional? Impact of Polysorbate 80 Grade and Quality on IgG Stability During Mechanical Stress.什么使聚山梨酯具有功能性?机械应力下聚山梨酯 80 级和质量对 IgG 稳定性的影响。
J Pharm Sci. 2020 Jan;109(1):871-880. doi: 10.1016/j.xphs.2019.10.015. Epub 2019 Oct 12.
10
Dessecting the toxicological profile of polysorbate 80 (PS80): comparative analysis of constituent variability and biological impact using a zebrafish model.剖析聚山梨酯80(PS80)的毒理学特征:使用斑马鱼模型对成分变异性和生物学影响进行比较分析。
Eur J Pharm Sci. 2024 Jul 1;198:106796. doi: 10.1016/j.ejps.2024.106796. Epub 2024 May 10.

本文引用的文献

1
Comparative Stability Study of Polysorbate 20 and Polysorbate 80 Related to Oxidative Degradation.聚山梨醇酯20和聚山梨醇酯80与氧化降解相关的稳定性比较研究
Pharmaceutics. 2023 Sep 16;15(9):2332. doi: 10.3390/pharmaceutics15092332.
2
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.蛋白质治疗药物中用于蛋白质稳定化的替代辅料:克服聚山梨酯的局限性
Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.
3
Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the Future.
行业视角下的聚山梨酯在生物制药产品中的应用和特性(第二部分):为未来做准备的控制策略调查报告。
J Pharm Sci. 2022 Nov;111(11):2955-2967. doi: 10.1016/j.xphs.2022.08.021. Epub 2022 Aug 21.
4
Poloxamer 188 as surfactant in biological formulations - An alternative for polysorbate 20/80?泊洛沙姆188作为生物制剂中的表面活性剂——聚山梨酯20/80的替代品?
Int J Pharm. 2022 May 25;620:121706. doi: 10.1016/j.ijpharm.2022.121706. Epub 2022 Apr 1.
5
Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of Polysorbates.生物制药产品中聚山梨酯使用及特性的行业视角 第1部分:聚山梨酯处理与控制的现状及常见做法调查报告
J Pharm Sci. 2022 May;111(5):1280-1291. doi: 10.1016/j.xphs.2022.02.009. Epub 2022 Feb 22.
6
Complex Micellization Behavior of the Polysorbates Tween 20 and Tween 80.聚山梨酯 20 和聚山梨酯 80 的复杂胶束化行为。
Mol Pharm. 2021 Aug 2;18(8):3147-3157. doi: 10.1021/acs.molpharmaceut.1c00406. Epub 2021 Jul 12.
7
Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection.开发并验证了一种基于选择性标记的 UPLC QDa 检测法,用于生物制药制剂中聚山梨酯 20 的定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Nov 10;1157:122287. doi: 10.1016/j.jchromb.2020.122287. Epub 2020 Jul 31.
8
Albumin displacement at the air-water interface by Tween (Polysorbate) surfactants.吐温(聚山梨酯)表面活性剂在气-液界面处对白蛋白的取代作用。
Eur Biophys J. 2020 Oct;49(7):533-547. doi: 10.1007/s00249-020-01459-4. Epub 2020 Sep 11.
9
Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.在水相条件下聚山梨酯的酸碱性水解:探索聚山梨酯在生物制药制剂中的降解。
Eur J Pharm Sci. 2020 Mar 1;144:105211. doi: 10.1016/j.ejps.2019.105211. Epub 2020 Jan 10.
10
Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes.生物治疗制剂中聚山梨酯的降解:现有根本原因的鉴定和讨论。
Int J Pharm. 2018 Dec 1;552(1-2):422-436. doi: 10.1016/j.ijpharm.2018.10.008. Epub 2018 Oct 6.